A Future Without Cancer
Founded in 1973 The National Foundation for Cancer Research (NFCR) supports cancer research and public education relating to the prevention, early diagnosis, better treatments and, ultimately, a cure for cancer. All of us, at NFCR, are committed to Research for a Cure, and we will not stop until we find a cure for all types of cancer.
Cancer Research Spectrum
Cancer research follows a path from an idea, through several stages of laboratory work, to clinical trials that, when successful, ends in FDA registration and approval. The process often takes between 7 and 15 years. Many promising and innovative discoveries stall inside laboratories, in what researchers refer as the “Valley of Death”, and die due to lack of funding. NFCR provides research funding support to help scientists launch discoveries and transcend the Valley of Death in search of breakthroughs in cancer treatment.
Research Support Through NFCR
NFCR provides outstanding researchers with the vital seed funding they need in their laboratories to pursue the next advancement in cancer research—more than $150 million since 1973. From life-saving breakthroughs in immunotherapy and anti-angiogenic therapies to advances in metastatic research, cancer genetics, precision medicine and more, NFCR-funded scientists have led the way into a new era of cancer prevention, detection, and treatment. We are committed to helping scientists translate promising cancer discoveries into cures by funding innovative research.
In the last decade, NFCR has supported:
Cancer Research Scientists
Discoveries and Breakthroughs.
With these breakthroughs, NFCR-funded scientists have established
Companies with new approaches to diagnosing and treating cancer, benefiting countless patients
The Power of Your Donation
Performs one biopsy to get tumor tissues from a patient for a variety of pathological tests and biological analyses
Buys one case of petri dishes for growing cancer cells – an essential first step to identify tumor markers or test treatment effectiveness of new drugs
Buys one antibody test to determine whether tumor cells have a specific marker for drug resistance
$1,000 – $2,500
Carries out a comprehensive genome-wide analysis on all genes in one tumor sample, for developing targeted and personalized cancer therapies
Conducts assays for evaluating anti-cancer effects of hybrid drugs in 8 cell lines of Triple Negative Breast Cancer
Buys immunoassay reagents for testing 6 autoantibodies in 2,000 tumor samples to establish effective biomarkers for early detection of ovarian cancer
Purchases a chemical library containing 5,000 compounds to identify new compounds that inhibit metastasis of prostate cancer in bone
Purchases a scanner to produce gene chip data that identifies new biomarkers for early detection and more effective treatment
Supports a Research Fellow to conduct critical laboratory cancer research for a year
$250,000 – $1 million
Supports an entire translational cancer research project for a year